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 CD4   +   Th1 cells are effectors in 
lupus nephritis — but what are 
their targets ? 
 Joshua D.  Ooi 1 and  A. Richard  Kitching 1 , 2 , 3 
 Lupus nephritis involves both humoral and cellular effectors. 
Okamoto and colleagues isolated renal CD4   +   cells from lupus-prone 
mice, selecting cells expressing T-cell receptors on the basis of 
their activity. After transfecting CD4   +   cells with the relevant T-cell 
receptors, they transferred them into mice and induced more severe 
glomerulonephritis. This study supports a direct role for Th1 cells in 
lupus nephritis, although their antigenic specificity remains uncertain, 
as they did not recognize nucleosomes. 
 Kidney International (2012)  82, 947 – 949.  doi: 10.1038/ki.2012.254 
 Systemic lupus erythematosus is the pro-
totypic systemic autoimmune disease, 
in which autoreactivity to multiple self 
antigens results in infl ammatory changes 
in and around the small vessels of multiple 
organs. Frequently, systemic lupus ery-
thematosus involves the glomerulus, 
exhibiting variable histological patterns, 
with the most severe forms of lupus 
nephritis featuring necrotizing and cres-
centic glomerulonephritis. Th e glomeru-
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lus is vulnerable to injury mediated by a 
variety of immunological and metabolic 
insults. Unfortunately, lupus nephritis 
exemplifi es this paradigm — with observa-
tions in humans of multiple immuno-
globulin isotypes, diff erent complement 
components, and innate cellular eff ectors. 
In addition to these mediators, both B 
cells and T cells are found in the kidneys 
of patients with lupus nephritis. In severe 
lupus nephritis, as in other forms of 
rapidly progressive glomerulonephritis, 
CD4   +   T cells are present within glome-
ruli. 1 Given this complex and diverse 
eff ector involvement, a better understand-
ing of eff ector responses in severe lupus 
nephritis is important for making progress 
in treatments for this disease. 
 Over the years, much eff ort has been 
focused on the role of immunoglobulin 
and humoral mediators in defining 
pathogenic effector mechanisms of 
glome rulonephritis. Cellular eff ectors are 
more diffi  cult to characterize and cellu lar 
immunity more diffi  cult to study. None-
theless, both the presence of effector 
T cells in lesions and their functional rele-
vance in experimental models of glome-
rulonephritis imply a role for CD4   +   cells 
in severe forms of glomerulonephritis, in 
addition to injurious humoral mediators. 
Eff ector T-helper cells, in the form of Th 1 
cells or Th 17 cells, activate innate eff ector 
cells and may also directly affect renal 
tissues. 2,3 Studies in experimental rapidly 
progressive glomerulonephritis have 
demonstrated a functional role for eff ector 
CD4   +   cells of both Th 1 and Th 17 type, 2 – 4 
with additional T-cell activation mediated 
by intrinsic kidney cells. In lupus nephri-
tis too, evidence supports a role for CD4   +  
cells and T cell-derived cytokines, such as 
interferon-  (known to activate macro-
phages), as eff ectors. 5,6 
 Okamoto  et al. 7 (this issue) identifi ed 
activated Th 1 CD4   +   cells from kidneys of 
MRL / lpr mice with lupus nephritis, show-
ing markers of activation, and expressing 
high levels of the T-cell receptor with 
interferon-  , but not Th 2 or Th 17 cyto-
kines. By single-cell sorting and T-cell 
receptor sequencing and reconstitution, 
they were able to transfect syngeneic 
CD4   +   cells with the T-cell receptor 
derived from the intrarenal T cell. Th ese 
transfected cells proliferated  in vivo , 
migrated to the kidney, and triggered 
nephritis in recipient prenephritic MRL /
 lpr mice. Progression and mortality were 
enhanced in mice receiving the most 
pathogenic T cells. Th e antigen-specifi c 
T cells were not found generally through-
out the body, implying some organ (and 
antigen) target specifi city. Th e migration 
of T cells to the kidney resulted in increa-
sed macrophage numbers in both the 
glomerulus and the tubulointerstitium. 
Th ese fi ndings are consistent with Th  cell-
derived interferon-  assisting, directly and 
indirectly, in macrophage recruitment and 
activation. However, not all transferred 
T cells were alike — of the two speci fi cities 
transferred, one was clearly more potent 
in causing injury. 
 A particular strength of the study is the 
isolation of a CD4   +   cell from the kidney 
whose T-cell receptor and phenotype 
could be recapitulated and which then 
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on transfer could migrate to the kidney 
and induce cell-mediated lupus-like 
glomerulonephritis. Based on the study 
by Okamoto  et al. 7 and previously pub-
lished literature,  Figure 1 outlines the 
potential involvement of Th 1 eff ector cells 
in lupus nephritis. Although the study by 
Okamoto  et al. addresses several ques-
tions, some key questions remain to be 
answered. What is the antigen specifi city 
of autoreactive eff ector CD4   +   cells — is it 
similar to the specificities of autoanti-
bodies detected? How do the autoantigens 
detected by effector T cells come to 
be present in the kidney? In lupus, as in 
other glomerular diseases, autoantigens 
can be intrinsic to the kidney, be planted 
in the kidney, or potentially be deposited 
in the kidney as components of circulat-
ing immune complexes. Only a small 
proportion of autoantibodies in systemic 
lupus erythematosus may be nephrito genic, 
but both in experimental models and in 
human disease a number of specifi  cities 
have been identified. 8 These include 
autoantibodies that react with basement 
membrane or matrix components (for 
example, laminin-1 and fi bronectin); those 
that react with endo genous cell-associated 
proteins (for example,   -actinin and 
annexin II), some of which crossreact with 
double-stranded DNA (dsDNA); and 
autoantibodies that react with autoantigens 
that have been planted in glomeruli (for 
example, nucleosomes and C1q). Renal 
T cells have a restricted clonality in lupus 
nephritis, 1 but the antigen specifi cities of 
pathogenic CD4   +   T cells in lupus nephritis 
are less well described. Nucleosomal con-
tents (including dsDNA and ribonucleo-
protein) are most frequently described, 9 
but the T cells derived from the kidneys in 
the study by Okamoto  et al. 7 did not proli-
ferate in response to nucleosomes, and their 
specificity remains undefined. Further-
more, whether eff ector T cells that localize 
to glomeruli recognize similar autoantigens 
to autoantibodies is not known. Is it possi-
ble that some eff ector CD4   +   cells in sys-
temic lupus erythe matosus (as suggested by 
Okamoto  et al. 7 ) do not promote autoanti-
body formation but do see antigens in 
glomeruli and induce injury? 
 How are these antigens recognized in 
the kidney by autoreactive T cells? Cell 
transfer studies have demonstrated that 
CD4   +   cells localize to glomeruli in an 
antigen-specifi c manner, 4 and local anti-
gen recognition is necessary for this pro-
cess. The tubulointerstitium is rich in 
dendritic cells, and tubular epithelial cells 
can present antigen locally. However, 
despite abundant evidence that antigen-
specifi c CD4   +   cells do localize to glome-
ruli, it is not clear how antigens are 
recog nized locally within glomeruli. Poten-
tially, professional antigen-presenting cells 
within glomeruli may play a role, although 
they are not prominent in glomeruli; or 
 ‘ non-professional ’ intrinsic glomerular 
cells such as glomerular endothelial cells or 
mesangial cells may be important. 
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 Figure 1  |  How Th1 cells may induce injury in lupus nephritis. ( a ) In lupus nephritis, antigens can be present in glomeruli as endogenous antigens 
(pink) that can be part of the extracellular matrix or associated with endothelial cells, podocytes, or mesangial cells (not shown here, for clarity). 
Alternatively, blood-borne lupus-related antigens can lodge within glomeruli (blue), either as free antigens or deposited as part of circulating immune 
complexes. ( b ) Autoreactive effector CD4   +   Th1 cells recognize their cognate autoantigen (not shown here; there are several potential mechanisms) 
and adhere in glomeruli. Production of interferon-  induces proinflammatory mediators such as chemokines and activates macrophages. 
Cell – cell contact via CD154 / CD40 is also important, promoting macrophage activation. This lesion has some of the features of a delayed-type 
hypersensitivity-like reaction, occurring in the kidney and resulting in diffuse proliferative lupus nephritis. CD40L, CD40 ligand; GBM, glomerular 
basement membrane; Mac, macrophage. 
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 Th e transfer of pathogenic T cells by 
Okamoto and colleagues 7 also induced 
increased glomerular complement depo-
sition without clear changes in serum 
IgG levels, anti-dsDNA levels, or overall 
glomerular IgG deposition, measured 
semiquantitatively. Nonetheless, it is 
possible that the transferred T cells did 
enhance glomerular deposition of patho-
genic autoantibodies with higher affi  nity 
or of a more damaging IgG subclass. 
Potentially, these autoantibodies could be 
responsible for the increased complement 
deposition found in the mice that received 
the pathogenic eff ector CD4   +   T cells. 
 Th e study by Okamoto  et al. 7 brings us 
a step closer to understanding how a vari-
ety of mediators, including eff ector CD4   +  
T cells, form an unholy alliance to mediate 
injury in lupus nephritis. Th e ultimate 
goal of new treatments, more targeted 
therapy with fewer side eff ects, may be 
more diffi  cult in patients with severe lupus 
nephritis because of both the potential 
diversity of target autoantigens and the 
involvement of multiple arms of the eff ec-
tor immune response. Over the past few 
years there has been real progress in using 
newer treatments, in the form of therapies 
such as mycophenolate and belimumab. 10 
However, already it has been shown that 
targeting autoimmunity to a  single anti-
gen, dsDNA, is not a useful treatment, 
even though dsDNA was a logical candi-
date antigen. 10 Th e diversity of clinical 
presentations and histological pictures in 
lupus and lupus nephritis may mean that 
in the future, treatment might need to be 
tailored in some patients to predominantly 
target one arm of the immune response, 
or even a restricted range of antigens. Fur-
ther well-designed studies in relevant and 
well-characterized experimental models 
of disease based on careful observations in 
humans need to be performed, so that we 
can better understand the nature of eff ec-
tor responses in this at-times devastating 
and diffi  cult-to-treat human disease. 
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 The glomerular endothelium 
emerges as a key player in 
diabetic nephropathy 
 Simon C.  Satchell 1 
 The effects of diabetes on glomerular structure and particularly that of 
the glomerular capillary wall have been extensively documented. By 
correlation with clinical measurements, Weil and colleagues provide 
important insights into the functional significance of glomerular 
structural changes in type 2 diabetes. Podocyte detachment correlates 
with albumin-to-creatinine ratio, but less strongly than does loss of 
endothelial fenestrations, which also correlates with reduced 
glomerular filtration rate. The role of the glomerular endothelium in 
diabetic nephropathy demands further scrutiny. 
 Kidney International (2012)  82, 949 – 951.  doi: 10.1038/ki.2012.258 
see original article on page 1010
 Th e glomerular fi ltration barrier is highly 
permeable to water and small molecules 
but maintains very low permeability to 
macromolecules. 1 Th ese characteristics 
are dependent on its unique three-layer 
structure. Glomerular endothelial cells are 
characterized by fenestrations, 60- to 80-
nm transcellular holes through the peri-
pheral cytoplasm, essential for high water 
permeability. 2 Th e glomerular basement 
membrane (GBM) separates glomerular 
endothelial cells from podocytes whose 
interdigitating foot processes are spanned 
by the slit diaphragm ( Figure 1 ). 
 Until recently, the presence of fenestra-
tions has meant that the glomerular 
endothelium has been considered to con-
tribute little to the barrier to macromol-
ecules. However, it is now appreciated that 
the luminal surface of the glomerular 
endothelium is covered with a glycocalyx, 
which forms a signifi cant permeability 
barrier. 1,3 Th e glycocalyx is a negatively 
charged hydrated mesh of cell-surface-
anchored proteoglycans and adsorbed 
proteins and glycosaminoglycans in 
dynamic equilibrium with the plasma. 4 
 Furthermore, the glomerular fi ltration 
barrier is now understood to function as 
an integrated whole: 1 disruption of the 
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